Accuracy of magnetic resonance imaging in diagnosis of liver iron overload: A systematic review and meta-analysis

Clinical Gastroenterology and Hepatology

Volumn 13, Issue 1, 2015, Pages 55-63.e5

  Sarigianni, Maria ^a,b   Liakos, Aris ^a   Vlachaki, Efthymia ^a   Paschos, Paschalis ^a   Athanasiadou, Eleni ^a   Montori, Victor M ^b   Murad, Mohammad Hassan ^b   Tsapas, Apostolos ^a,c  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Diagnostic accuracy meta analysis; Sickle cell disease; Thalassemia

Indexed keywords

IRON;

ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; HEMOCHROMATOSIS; HEMOGLOBINOPATHY; HUMAN; IRON OVERLOAD; LIVER BIOPSY; LIVER LEVEL; META ANALYSIS; MYELODYSPLASTIC SYNDROME; NUCLEAR MAGNETIC RESONANCE IMAGING; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; CHELATION THERAPY; DRUG MONITORING; EVALUATION STUDY; LIVER; PROCEDURES; RADIOGRAPHY;

CHELATION THERAPY; DRUG MONITORING; HUMANS; IRON OVERLOAD; LIVER; MAGNETIC RESONANCE IMAGING;

EID: 84916915830     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2014.05.027     Document Type: Article

References (46)

1. Brittenham G.M., Badman D.G. Noninvasive measurement of iron: report of an NIDDK workshop. Blood 2003, 101:15-19.
2. van Bokhoven M.A., van Deursen C.T., Swinkels D.W. Diagnosis and management of hereditary haemochromatosis. BMJ 2011, 342:c7251.
3. Angelucci E., Brittenham G.M., McLaren C.E., et al. Hepatic iron concentration and total body iron stores in thalassemia major. NEngl J Med 2000, 343:327-331.
4. Barry M., Sherlock S. Measurement of liver-iron concentration in needle-biopsy specimens. Lancet 1971, 1:100-103.
5. Cogliandro T., Derchi G., Mancuso L., et al. Guideline recommendations for heart complications in thalassemia major. JCardiovasc Med (Hagerstown) 2008, 9:515-525.
6. Hoffbrand A.V., Taher A., Cappellini M.D. How I treat transfusional iron overload. Blood 2012, 120:3657-3669.
7. Remacha A., Sanz C., Contreras E., et al. Guidelines on haemovigilance of post-transfusional iron overload. Blood Transfus 2013, 11:128-139.
8. Thalassaemia International Federation. Guidelines for the clinical management of thalassemia. 2nd ed. Cyprus: Thalassaemia International Federation,2008.
9. Anderson L.J., Holden S., Davis B., et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001, 22:2171-2179.
10. Gandon Y., Olivie D., Guyader D., et al. Non-invasive assessment of hepatic iron stores by MRI. Lancet 2004, 363:357-362.
11. St Pierre T.G., Clark P.R., Chua-anusorn W., et al. Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood 2005, 105:855-861.
12. Wood J.C., Enriquez C., Ghugre N., et al. MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood 2005, 106:1460-1465.
13. Ho P.J., Tay L., Lindeman R., et al. Australian guidelines for the assessment of iron overload and iron chelation in transfusion-dependent thalassaemia major, sickle cell disease and other congenital anaemias. Intern Med J 2011, 41:516-524.
14. Angelucci E., Barosi G., Camaschella C., et al. Italian Society of Hematology practice guidelines for the management of iron overload in thalassemia major and related disorders. Haematologica 2008, 93:741-752.
15. Moher D., Liberati A., Tetzlaff J., et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009, 151:264-269.
16. Kreeftenberg H.G., Mooyaart E.L., Huizenga J.R., et al. Quantification of liver iron concentration with magnetic resonance imaging by combining T1-, T2-weighted spin echo sequences and a gradient echo sequence. Neth J Med 2000, 56:133-137.
17. Rocchi E., Cassanelli M., Borghi A., et al. Magnetic resonance imaging and different levels of iron overload in chronic liver disease. Hepatology 1993, 17:997-1002.
18. Olivieri N.F., Brittenham G.M. Iron-chelating therapy and the treatment of thalassemia. Blood 1997, 89:739-761.
19. Whiting P.F., Rutjes A.W., Westwood M.E., et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 2011, 155:529-536.
20. Dwamena B.A. midas: A program for Meta-analytical Integration of Diagnostic Accuracy Studies in Stata 2007, University of Michigan, Ann Arbor.
21. Harbord R.M., Whiting P. Metandi: meta-analysis of diagnostic accuracy using hierarchical logistic regression. Stata J 2009, 9:211-229.
22. Higgins J.P., Thompson S.G., Deeks J.J., et al. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
23. Deeks J.J., Macaskill P., Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. JClin Epidemiol 2005, 58:882-893.
24. Alexopoulou E., Stripeli F., Baras P., et al. R2 relaxometry with MRI for the quantification of tissue iron overload in beta-thalassemic patients. JMagn Reson Imaging 2006, 23:163-170.
25. Chan Y.L., Li C.K., Lam C.W., et al. Liver iron estimation in beta-thalassaemia: comparison of MRI biochemical assay and histological grading. Clin Radiol 2001, 56:911-916.
26. de Assis R.A., Ribeiro A.A., Kay F.U., et al. Pancreatic iron stores assessed by magnetic resonance imaging (MRI) in beta thalassemic patients. Eur J Radiol 2012, 81:1465-1470.
27. Engelhardt R. Liver iron quantification: studies in aqueous iron solutions, iron overloaded rats, and patients with hereditary hemochromatosis. Magn Reson Imaging 1994, 12:999-1007.
28. Garbowski M.W., Carpenter J.-P., Smith G., et al. Calibration of improved T2* method for the estimation of liver iron concentration in transfusional iron overload. Blood 2009, 114. abstract 2004.
29. Hankins J.S., McCarville M.B., Loeffler R.B., et al. R2* magnetic resonance imaging of the liver in patients with iron overload. Blood 2009, 113:4853-4855.
30. Jensen P.D., Jensen F.T., Christensen T., et al. Non-invasive assessment of tissue iron overload in the liver by magnetic resonance imaging. Br J Haematol 1994, 87:171-184.
31. Lawrence S.P., Caminer S.J., Yavorski R.T., et al. Correlation of liver density by magnetic resonance imaging and hepatic iron levels. A noninvasive means to exclude homozygous hemochromatosis. JClin Gastroenterol 1996, 23:113-117.
32. Macfarlane J.D., Vreugdenhil G.R., Doornbos J., et al. Idiopathic haemochromatosis: magnetic resonance signal intensity ratios permit non-invasive diagnosis of low levels of iron overload. Neth J Med 1995, 47:49-53.
33. Ooi G.C., Khong P.L., Chan G.C., et al. Magnetic resonance screening of iron status in transfusion-dependent beta-thalassaemia patients. Br J Haematol 2004, 124:385-390.
34. Rose C., Vandevenne P., Bourgeois E., et al. Liver iron content assessment by routine and simple magnetic resonance imaging procedure in highly transfused patients. Eur J Haematol 2006, 77:145-149.
35. St Pierre T.G., El-Beshlawy A., Elalfy M., et al. Multicenter validation of spin-density projection-assisted R2-MRI for the noninvasive measurement of liver iron concentration. Magn Reson Med 2014, 71:2215-2223.
36. Tang H., Jensen J.H., Sammet C.L., et al. MR characterization of hepatic storage iron in transfusional iron overload. JMagn Reson Imaging 2013, 39:307-316.
37. Voskaridou E., Douskou M., Terpos E., et al. Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease. Br J Haematol 2004, 126:736-742.
38. Macaskill P., Gatsonis C., Deeks J., et al. Chapter 10: analysing and presenting results. Cochrane handbook for systematic reviews of diagnostic test accuracy 2010, the Cochrane collaboration, London, UK. J.J. Deeks, P.M. Bossuyt, C. Gatsonis (Eds.).
39. Trikalinos T.A., Balion C.M., Coleman C.I., et al. Chapter 8: meta-analysis of test performance when there is a "gold standard". JGen Intern Med 2012, 27(Suppl):S56-S66.
40. Cappellini M.D., Bejaoui M., Agaoglu L., et al. Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: efficacy and safety during 5 years' follow-up. Blood 2011, 118:884-893.
41. Jaeschke R., Guyatt G.H., Sackett D.L. Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA 1994, 271:703-707.
42. Bossuyt P.M., Reitsma J.B., Bruns D.E., et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD Initiative. Radiology 2003, 226:24-28.
43. Emond M.J., Bronner M.P., Carlson T.H., et al. Quantitative study of the variability of hepatic iron concentrations. Clin Chem 1999, 45:340-346.
44. Leeflang M.M., Moons K.G., Reitsma J.B., et al. Bias in sensitivity and specificity caused by data-driven selection of optimal cutoff values: mechanisms, magnitude, and solutions. Clin Chem 2008, 54:729-737.
45. Westwood M.A., Anderson L.J., Firmin D.N., et al. Interscanner reproducibility of cardiovascular magnetic resonance T2* measurements of tissue iron in thalassemia. JMagn Reson Imaging 2003, 18:616-620.
46. US Food and Drug Administration. FDA approves Exjade to remove excess iron in patients with genetic blood disorder. 2013. Available at: Accessed October 31,2013. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm336478.htm.